Bank of New York Mellon’s TriSalus Life Sciences TLSI Stock Holding History

Bank of New York Mellon’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Buy	111,534 +45,730	+69%	+$182K	﹤0.01%	3749
2026 Q1	$263K	Buy	65,804 +1,200	+2%	+$5.88K	﹤0.01%	3907
2025 Q4	$451K	Buy	64,604 +17,900	+38%	+$100K	﹤0.01%	3669
2025 Q3	$217K	Buy	46,704 +4,903	+12%	+$23K	﹤0.01%	3978
2025 Q2	$228K	Buy	+41,801	New	+$224K	﹤0.01%	3932

Other funds holding TLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CWM

Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Bank of New York Mellon's TLSI Position: Q2 2026 in Review

Bank of New York Mellon increased its TriSalus Life Sciences (TLSI) stake by 69% in Q2 2026, buying an estimated $182K and bringing the position to 111,534 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

Bank of New York Mellon first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. 33 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Bank of New York Mellon held 111,534 shares of TriSalus Life Sciences worth $507K as of Q2 2026.
Bank of New York Mellon bought 45,730 TriSalus Life Sciences shares in Q2 2026, an estimated $182K.
TriSalus Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3749 holding.
Bank of New York Mellon first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
33 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.